Edgar H. Ulm
Nessuna posizione attualmente
Profilo
Edgar H.
Ulm held several positions in the pharmaceutical industry, including Director at Ligand Pharmaceuticals, Senior Director-Oncology Research & Development at Biogen, Principal at Merck & Co., Vice President-PreClinical Development at Conforma Therapeutics Corp., Principal at Magellan Laboratories, and Head-Development at Intellikine LLC.
Ulm earned a doctorate degree from Purdue University.
Precedenti posizioni note di Edgar H. Ulm
| Società | Posizione | Fine |
|---|---|---|
Magellan Laboratories, Inc.
 Magellan Laboratories, Inc. BiotechnologyHealth Technology Part of Cardinal Health, Inc., Magellan Laboratories, Inc. provides product development services of biological products. The company is based in Morrisville, NC. Magellan Laboratories was acquired by Cardinal Health, Inc. on March 18, 2002. | Corporate Officer/Principal | - |
| MERCK & CO., INC. | Corporate Officer/Principal | - |
| LIGAND PHARMACEUTICALS INCORPORATED | Direttore/Membro del Consiglio | - |
Conforma Therapeutics Corp.
 Conforma Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Conforma Therapeutics Corp. designs and develops drugs for treatment of cancer. It also develops applications in the areas of medicine, including inflammation, virology and central nervous system disorders. The company was founded in 1999 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
| BIOGEN INC. | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Edgar H. Ulm
| Purdue University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| BIOGEN INC. | Health Technology |
| LIGAND PHARMACEUTICALS INCORPORATED | Health Technology |
| MERCK & CO., INC. | Health Technology |
| Aziende private | 3 |
|---|---|
Intellikine LLC
 Intellikine LLC Pharmaceuticals: MajorHealth Technology Intellikine LLC develops and manufactures small molecule drugs for the treatment of cancer. The company focused on the development of potent, selective small molecule inhibitors of the PI3K/Akt/mTOR pathway for the treatment of cancer, inflammation and autoimmune disorders. Intellikine was founded on May 2nd, 2007 and is headquartered in La Jolla, CA. | Health Technology |
Conforma Therapeutics Corp.
Conforma Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Conforma Therapeutics Corp. designs and develops drugs for treatment of cancer. It also develops applications in the areas of medicine, including inflammation, virology and central nervous system disorders. The company was founded in 1999 and is headquartered in Cambridge, MA. | Health Technology |
Magellan Laboratories, Inc.
Magellan Laboratories, Inc. BiotechnologyHealth Technology Part of Cardinal Health, Inc., Magellan Laboratories, Inc. provides product development services of biological products. The company is based in Morrisville, NC. Magellan Laboratories was acquired by Cardinal Health, Inc. on March 18, 2002. | Health Technology |
- Borsa valori
- Insiders
- Edgar H. Ulm
